People with multiple sclerosis experience subtle language impairments, study shows

NewsGuard 100/100 Score

Kessler Foundation researchers showed that people with multiple sclerosis (MS) experience subtle language impairments that standard neuropsychological tests may incorrectly attribute to impaired executive functions.

The article, "The role of language ability in verbal fluency of individuals with multiple sclerosis" was published on February 16, 2021, in Multiple Sclerosis and Related Disorders.

The authors are Nancy D. Chiaravalloti, PhD, director of the Centers for Neuropsychology, Neuroscience, and Traumatic Brain Injury Research at Kessler Foundation, Lauren B. Strober, PhD, senior research scientist at the Center for Neuropsychology and Neuroscience Research, and Amy L. Lebkuecher, MS, of Pennsylvania State University, formerly of Kessler Foundation. Drs. Chiaravalotti and Strober also have research faculty appointments at Rutgers New Jersey Medical School.

Assessing language ability in people with MS is a complicated endeavor, given the vast spectrum of individual clinical experiences within this population. Yet the ability to identify any form of language impairment, not just severe language disorder, is essential to fully understanding a patient's cognitive profile and providing optimal interventions.

While some early research suggested that language ability is largely intact in people with MS, newer studies indicate that milder language impairments may exist but are too subtle to be quantified by standard neuropsychological tests.

As a result, verbal fluency deficits observed in MS are often attributed to impaired processing speed and executive functions rather than language ability. Because individuals with MS have been presumed to have intact language ability, more comprehensive tests are rarely performed, according to lead author Dr. Lebkuecher.

In this study, the Kessler research team challenged the assumption that impaired verbal fluency of individuals with MS solely reflects executive dysfunction. The team analyzed pre-existing data from 74 individuals with MS to evaluate the contribution of various cognitive factors to verbal fluency, including language ability, oral-motor speed, processing speed, and executive functions.

They conducted linear multiple regression analyses with letter and category verbal fluency--which relate to a person's ability to produce words starting with a given letter or within a semantic category--as outcome variables.

The results showed that vocabulary and processing speed predicted letter fluency, while only vocabulary predicted category fluency. Although further research is needed to better understand the relationship between verbal fluency and vocabulary and processing speed, the results suggest the observed verbal fluency deficits in MS may reflect both impaired language ability and processing speed.

Our results indicate that language ability and domain-general factors were predictive of verbal fluency in individuals with MS. Specifically, language ability played a significant role. This could indicate that verbal fluency deficits in MS reflect underlying language impairment. Our findings further demonstrate the need for more comprehensive examination of language in people with MS."

Nancy D. Chiaravalloti, PhD, Director, Centers for Neuropsychology, Neuroscience, and Traumatic Brain Injury Research, Kessler Foundation

Source:
Journal reference:

Lebkuecher, A. L., et al. (2021) The role of language ability in verbal fluency of individuals with multiple sclerosis. Multiple Sclerosis and Related Disorders. doi.org/10.1016/j.msard.2021.102846.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Targeting the Hippo signaling pathway to treat systemic sclerosis